Skip to main content

NewLake Capital Partners Inc

For the period ended Dec 31, 2024. Filed Mar 6, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 6, 2025

NLCPStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 2. Properties

Our Properties

We seek to acquire specialized real estate assets used for cultivation and processing of cannabis as well as retail dispensaries that are strategic profit centers for our tenants and are well positioned for the regulatory evolution of the industry. These licensed facilities are critical components of the cannabis industry, particularly in limited-license jurisdictions. As of December 31, 2024, we owned 32 properties comprised of 17 dispensaries and 15 cultivation facilities that are 100% leased to state-licensed cannabis operators, with a weighted average remaining lease term of 13.39 years. Based on invested capital, as of December 31, 2024, our portfolio is comprised of approximately 91.1% cultivation facilities and 8.9% dispensaries.

As of December 31, 2024, we have aggregate unfunded commitments to invest $11.0 million for the development and improvement of our existing cultivation facility in Connecticut. We define these improvement allowances as a commitment pursuant to our lease with the tenant to fund alterations, additions or improvements to the premises. Our leases are generally structured to disburse capital over specified periods of time. The leases also generally contain certain provisions that require tenants to pay rent on the full amount of capital under each lease, whether or not disbursed.

Existing Portfolio. The table below sets forth our property portfolio as of December 31, 2024 (in thousands, except square feet):

Property Type · State · Tenant(1) · Rentable Square Feet(2) · Investment in Real Estate(3) · Real Estate Construction in Progress · Total Real Estate · In-Place Lease Intangible Assets(4) · Total Investment
CultivationFloridaCuraleaf417,350$75,983$—$75,983$—$75,983
CultivationIllinoisCresco Labs222,45550,732—50,732—50,732
CultivationMassachusettsRevolutionary Clinics, Inc.145,85242,860—42,860—42,860(5)
CultivationPennsylvaniaTrulieve144,60244,270—44,27012,33156,601
CultivationArizonaMint100,75821,810—21,810—21,810
CultivationPennsylvaniaCalypso Enterprises99,20031,0071,00632,013—32,013
CultivationMissouriC3 Industries, Inc.94,57029,017—29,017—29,017
CultivationMissouriOrganic Remedies81,80821,101—21,101—21,101
CultivationConnecticutC3 Industries, Inc.58,4363,9939814,974—4,974
CultivationNevadaAYR Wellness56,53613,579—13,579—13,579
CultivationMassachusettsThe Cannabist Company38,89013,826—13,8264,12017,946
CultivationMassachusettsAcreage38,3809,791—9,791—9,791
CultivationPennsylvaniaAYR Wellness38,03115,278—15,278—15,278
CultivationIllinoisThe Cannabist Company32,80211,361—11,3613,10614,467
CultivationPennsylvaniaAcreage30,62510,161—10,161—10,161
DispensaryConnecticutCuraleaf11,1812,930—2,9304413,371
DispensaryMassachusettsPharmaCann11,1162,112—2,1123632,475
DispensaryArkansasGreenlight7,5922,157—2,1573202,477
DispensaryOhioCuraleaf7,2003,353—3,3535823,935
DispensaryIllinoisCuraleaf6,1001,734—1,7342571,991
DispensaryIllinoisCuraleaf5,0403,362—3,3625753,937
DispensaryIllinoisThe Cannabist Company4,7361,215—1,2152061,421
DispensaryNorth DakotaCuraleaf4,5902,174—2,1743552,529
DispensaryMassachusettsThe Cannabist Company4,2902,320—2,3203732,693
DispensaryIllinoisCuraleaf4,2001,024—1,0241781,202
DispensaryOhioPharmaCann3,7351,550—1,550—1,550
DispensaryPennsylvaniaCuraleaf3,5002,226—2,2263692,595
DispensaryPennsylvaniaPharmaCann3,4811,315—1,3152561,571
DispensaryConnecticutAcreage2,872929—929—929
DispensaryCaliforniaThe Cannabist Company2,4703,774—3,7741,0714,845
DispensaryPennsylvaniaCuraleaf1,9681,918—1,9183202,238
DispensaryIllinoisCuraleaf1,851594—59498692
Total1,686,217$429,456$1,987$431,443$25,321$456,764

(1) Lease is with a subsidiary of this entity, for which this entity or an affiliate is a guarantor.

(2) Includes estimated rentable square feet at completion of construction.

(3) Includes the purchase price (and in some cases, transaction costs that have been capitalized into the purchase price) and building and improvement commitments funded, if any, as of December 31, 2024. Excludes building and improvement commitments not funded as of December 31, 2024.

(4) Represents gross In-Place Intangibles at acquisition. Does not include accumulated amortization.

(5) Includes approximately $40.0 million in cash and 88,200 OP Units issued in connection with the purchase of the property.

The following table sets forth a summary of the lease expirations for leases in place as of December 31, 2024 for each of the ten full calendar years beginning January 1, 2025. The information set forth in the table does not assume exercise of renewal options by tenants (square footage and annualized base rent in thousands).

Year of Lease ExpirationNumber of Leases ExpiringSquare Footage of Leases Expiring% of Portfolio Net Rentable Square FeetAnnualized Base Rent(1)% of Portfolio Annualized Base RentAnnualized Base Rent per Leased Square Foot(2)
2025———%$——%$—
2026———%——%—
2027———%——%—
2028———%——%—
20293110.7%8781.7%76.33
2030———%——%—
20312150.9%4110.8%28.13
20328442.6%1,7293.4%39.66
20332100.6%5851.1%60.77
2034544226.2%15,78130.7%35.73
Thereafter121,16569.0%32,05162.3%27.50
Total/Weighted Average321,686100.0%$51,434100.0%$30.50

(1) Annualized base rent is calculated by multiplying (i) contractual rental income (including contractual rent from two non-performing tenants since the leases had not be modified as of December 31, 2024, and excluding reimbursable revenues) for the month ended December 31, 2024, by (ii) 12.

(2) Annualized base rent per leased square foot is calculated by dividing (i) annualized contractual base rent (including contractual rent from two non-performing tenants since the leases had not be modified as of December 31, 2024 and excluding reimbursable revenues) by (ii) net rentable square feet. Amounts may not recalculate due to rounding.

We target companies that have successfully navigated complex state regulation and fulfilled rigorous state-licensing requirements. We believe we have been diligent in partnering with a diverse tenant base of experienced operators in limited licensed jurisdictions that have strong management teams. Our tenants have generally demonstrated access to capital, which is critical to continuing to execute on their respective business plans.

As of December 31, 2024, all of our revenues were derived from 13 tenants. The following table sets forth the tenants in our property portfolio as of December 31, 2024 (dollars in thousands). All of our leases include a parent or other affiliate guarantee.

Tenant(1)Total Investment(2)Number of LeasesPercentage of Annualized Rental Income(3)
Curaleaf$98,4741022.8%
Cresco Labs50,732112.9%
Trulieve56,601111.0%
The Cannabist Company41,37358.2%
C3 Industries33,99027.5%
Calypso Enterprises32,01317.1%
Acreage20,88036.6%
Mint21,81015.9%
Ayr Wellness28,85725.8%
Revolutionary Clinics, Inc.42,86015.7%
Organic Remedies21,10114.8%
PharmaCann5,59531.2%
Greenlight2,47810.5%
Total$456,76432100.0%

(1) Lease may be with a subsidiary of this entity, for which this entity or an affiliate is a guarantor.

(2) Includes the purchase price (and in some cases, transaction costs that have been capitalized into the purchase price), gross In-Place Lease Intangible Assets and building and improvement commitments funded, if any, as of December 31, 2024. Excludes building and improvement commitments not funded as of December 31, 2024.

(3) Annualized Rental Income is calculated by multiplying (i) contractual rental income (including contractual rent from two non-performing tenants since the leases had not be modified as of December 31, 2024, and excluding reimbursable revenues) for the month ended December 31, 2024, by (ii) 12.

Curaleaf

We own nine dispensaries and one cultivation facility that are leased to subsidiaries of Curaleaf, which is, or an affiliate is, the corporate guarantor. Curaleaf is publicly-traded on the TSX and OTC markets under the symbols CURA and CURLF, respectively. Curaleaf’s filings, including their financial information, are electronically available at www.sec.gov and from the Canadian System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com, the Canadian equivalent of the SEC electronic document gathering and retrieval system.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.